Search
for
Sort by
Research 511–540 of 1000+
- Risk of erythrocytosis in transgender individuals undergoing testosterone therapy: a systematic review
- Pre‐polycystic ovary syndrome and polymenorrhoea as new facets of polycystic ovary syndrome (PCOS): Evidences from a single centre data set
- Higher prevalence of clinical cardiovascular comorbidities in postmenopausal women with self-reported premenopausal hirsutism and/or oligo-amenorrhea
- Menopausal Androgen Excess - Associated Cardio-Metabolic Risk: Clues for Ovarian Leydig Cell Tumour (Case Report and Mini-Review of Literature)
- Sertoli–Leydig cell tumors: hormonal profile after dynamic test with GnRH analogue: triptorelin represents a useful tool to evaluate tumoral hyperandrogenism
- Hair-cycle dependent differential expression of ADAM 10 and ADAM 12
- Modern approaches to diagnostics of hyperandrogenism distributed forms in reproductive aged women
- Haplotype analysis of<i>VEGF</i>gene polymorphisms in polycystic ovary syndrome
- Insulin resistance and β-cell dysfunction and the relationship with cardio-metabolic disorders among women with polycystic ovary syndrome
- Concurrence of giant cell arteritis in a patient with de quervain's thyroiditis
- Measuring steroids in hair opens up possibilities to identify congenital adrenal hyperplasia in developing countries
- Diagnostic imaging in congenital adrenal hyperplasia – how does it help?
- Hyperandrogenism in a postmenopausal woman: a rare case of ectopic adrenal cortical gland
- A rare case of an androgen-producing stromal luteoma of the ovary in a postmenopausal woman, diagnosed by means of selective venous blood sampling
- Long-term satisfaction and tolerability with low-dose flutamide: a 20-year surveillance study on 120 hyperandrogenic women
- Thyroid Disease in Alopecia Areata, Lichen Planopilaris, and Frontal Fibrosing Alopecia—A Case Control Study of 144 Patients
- Is 3α, 17β-androstanediol-glucuronide a diagnostic marker in women with androgenic manifestations?
- Polycystic Ovary Syndrome in the Context of Pituitary Adenomas: Prevalence, Pathophysiology and Clinical Management
- Does <i>myo</i>-inositol oxygenase, the only enzyme to catalyze <i>myo</i>-inositol <i>in vivo</i>, play a role in the etiology of polycystic ovarian syndrome?
- Androgenic alopecia, premature graying, and hair thinning as independent predictors of coronary artery disease in young Asian males
- Latent polyglandular autoimmune syndrome type 2 case diagnosed during a shock manifestation
- Predictors of Scalp Hair Thinning in Women with Polycystic Ovary Syndrome
- Comparison of resumption of ovulation after cessation of oral contraceptives and medroxyprogesterone acetate in women with polycystic ovary syndrome
- Hereditary vitamin D resistant rickets (HVDRR) case series: phenotype, genotype, conventional treatment, and adjunctive cinacalcet therapy
- Evaluation of androgen-dependent skin findings of polycystic ovary syndrome (PCOS)
- Practical approaches to the use of markers of biochemical hyperandrogenism in women
- Influence of conditioned media from glial cell cultures on contractility of uterine in rats of different ages
- Diagnostik und Therapie bei Haarausfall und Hirsutismus
- Androgenisierung
- Einfluss von HRT auf Haut und Haare